Relating to prescription drugs; enacting the prescription drug price transparency act to increase transparency across the prescription drug supply chain; requiring prescription drug manufacturers, pharmacy services administrative organizations, health insurers and pharmacy benefits managers to report prescription drug price trends to the superintendent of insurance; requiring the superintendent of insurance to collect and publicly report aggregate information on prescription drug price trends; prescribing civil penalties; making an appropriation.